5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.03▲ | 1.03▲ | 1.04▲ | 1.04▼ | 1.03▲ |
MA10 | 1.04▲ | 1.04▲ | 1.05▲ | 1.04▲ | 1.06▼ |
MA20 | 1.04▲ | 1.04▲ | 1.04▲ | 1.03▲ | 1.13▼ |
MA50 | 1.04▲ | 1.04▲ | 1.04▲ | 1.07▼ | 1.24▼ |
MA100 | 1.03▲ | 1.02▲ | 1.04▲ | 1.14▼ | 1.26▼ |
MA200 | 1.04▲ | 1.07▼ | 1.09▼ | 1.20▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.001▼ | 0.000▲ | 0.004▲ | -0.004▼ |
RSI | 55.710▲ | 55.044▲ | 54.105▲ | 48.306▼ | 40.931▼ |
STOCH | 19.048▼ | 17.460▼ | 35.185 | 45.238 | 43.335 |
WILL %R | -44.444 | -44.444 | -44.444 | -57.143 | -58.787 |
CCI | 33.586 | 24.762 | 48.185 | 57.705 | -64.925 |
Saturday, April 19, 2025 07:46 PM
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades ...
|
Tuesday, April 15, 2025 01:02 AM
Vivani Medical, Inc. (NASDAQ:VANI) and Okava Pharmaceuticals, Inc. expanded their collaboration to include dogs in the development of OKV-119, a long-acting GLP-1 therapy for weight management ...
|
Monday, April 14, 2025 10:03 PM
Vivani Medical, Inc. (NASDAQ:VANI) and Okava Pharmaceuticals, Inc. expanded their collaboration to include dogs in the development of OKV-119, a long-acting GLP-1 therapy for weight management, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.05 | 1.055 | 1.04 | 1.04 | 21,782 |
30/04/25 | 1.02 | 1.04 | 1.02 | 1.03 | 20,825 |
29/04/25 | 1.045 | 1.07 | 1.045 | 1.045 | 27,919 |
28/04/25 | 1.05 | 1.06 | 1.04 | 1.05 | 25,049 |
25/04/25 | 1.01 | 1.05 | 1.01 | 1.05 | 44,028 |
24/04/25 | 1.02 | 1.04 | 1.01 | 1.03 | 42,897 |
23/04/25 | 1.03 | 1.05 | 1.0235 | 1.03 | 37,731 |
22/04/25 | 1.02 | 1.03 | 1.01 | 1.02 | 28,526 |
21/04/25 | 1.06 | 1.0612 | 1.01 | 1.02 | 106,540 |
17/04/25 | 1.05 | 1.08 | 1.04 | 1.06 | 63,959 |
|
|
||||
|
|
||||
|
|